1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy
    Editorial

    Luttwak, E.; Smith, M. R.; Zelenetz, A. D.
    Expert Opinion on Pharmacotherapy (2023)

    Fulltext@MSK | Save
  • Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients
    Journal Article

    Mahmood, S. S.; Riedell, P. A.; Feldman, S.; George, G.; Sansoterra, S. A.; Althaus, T.; Rehman, M.; Mead, E.; Liu, J. E.; Devereux, R. B.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
    Correspondence

    Gribben, J.; Palomba, M. L.; Patel, A. R.; Nahas, M.; Neelapu, S. S.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
    Research Letter

    Santoro, A.; Moskowitz, A. J.; Ferrari, S.; Carlo-Stella, C.; Lisano, J.; Francis, S.; Wen, R. C.; Akyol, A.; Savage, K. J.
    Blood (2023)

    Fulltext@MSK | Save
  • Report of consensus panel 7 from the 11th International Workshop on Waldenström Macroglobulinemia on priorities for novel clinical trials
    Conference Paper

    Tam, C. S.; Kapoor, P.; Castillo, J. J.; Buske, C.; Ansell, S. M.; Branagan, A. R.; Kimby, E.; Li, Y.; Palomba, M. L.; Qiu, L.; more...
    W.B. Saunders Co-Elsevier Inc. (2023)

    Fulltext@MSK | Save
  • Treatment of adult T-cell leukemia/lymphoma: Established paradigms and emerging directions
    Review

    Stuver, R.; Horwitz, S. M.; Epstein-Peterson, Z. D.
    Current Treatment Options in Oncology (2023)

    Fulltext@MSK | Save
  • Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T-cell lymphoma
    Journal Article

    Stuver, R.; Horwitz, S. M.; Advani, R. H.; Vose, J. M.; Lee, H. J.; Mehta-Shah, N.; Zain, J. M.; Haverkos, B.; Lechowicz, M. J.; Moskowitz, A. J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells
    Journal Article

    Lareau, C. A.; Dubois, S. M.; Buquicchio, F. A.; Hsieh, Y. H.; Garg, K.; Kautz, P.; Nitsch, L.; Praktiknjo, S. D.; Maschmeyer, P.; Verboon, J. M.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Future directions in the frontline management of Waldenström macroglobulinemia
    Review

    Buske, C.; Palomba, M. L.
    Hematology/Oncology Clinics of North America (2023)

    Fulltext@MSK | Save